Myriad grants one-time retention options to CFO, COO and CSO; full vest on third anniversary

MYRIAD GENETICS INC

Compensation Committee approved Nov 6, 2026 awards: CFO Benjamin R. Wheeler 121,379 options, COO Mark S. Verratti 146,933, CSO Dale Muzzey 92,632.
Exercise price equals Myriad's closing stock price on the grant date; options vest and become exercisable in full on the third anniversary, subject to continued service.
Options have a 10-year term; vested portions generally stay exercisable three months after termination other than death, disability or cause, and terminate immediately for cause.
Company said the awards are meant to retain leadership continuity as it executes initiatives to improve operational efficiencies and financial performance.
Awards remain subject to each executive's existing Severance and Change in Control Agreement; grants were made under the 2026 Equity Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.